Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome

Detalhes bibliográficos
Autor(a) principal: Campanha, Fábio V.G. [UNESP]
Data de Publicação: 2016
Outros Autores: Perone, Denise [UNESP], de Campos, Dijon H.S. [UNESP], de Luvizotto, Renata A. M., de Síbio, Maria T. [UNESP], de Oliveira, Miriane [UNESP], Olimpio, Regiane M. C. [UNESP], Moretto, Fernanda C. F. [UNESP], Padovani, Carlos R. [UNESP], Mazeto, Gláucia M.F.S. [UNESP], Cicogna, Antonio C. [UNESP], Nogueira, Célia R. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1590/2359-3997000000208
http://hdl.handle.net/11449/173914
Resumo: Objective: The current study was aimed at analyzing sarcoplasmic reticulum Ca2+ ATPase (Serca2) and ryanodine receptor type 2 (Ryr2) gene expression in rats subjected to surgery that induced HF and were subsequently treated with T4 using physiological doses. Materials and methods: HF was induced in 18 male Wistar rats by clipping the ascending thoracic aorta to generate aortic stenosis (HFS group), while the control group (9-sham) underwent thoracotomy. After 21 weeks, the HFS group was subdivided into two subgroups. One group (9 Wistar rats) with HF received 1.0 µg of T4/100 g of body weight for five consecutive days (HFS/T4); the other group (9 Wistar rats) received isotonic saline solution (HFS/S). The animals were sacrificed after this treatment and examined for signs of HF. Samples from the left ventricles of these animals were analyzed by RT-qPCR for the expression of Serca2 and Ryr2 genes. Results: Rats with HF developed euthyroid sick syndrome (ESS) and treatment with T4 restored the T3 values to the Sham level and increased Serca2 and Ryr2 gene expression, thereby demonstrating a possible benefit of T4 treatment for heart function in ESS associated with HF. Conclusion: The T4 treatment can potentially normalize the levels of T3 as well elevated Serca2 and Ryr2 gene expression in the myocardium in heart failure rats with euthyroid sick syndrome.
id UNSP_ac68524d934f4f85f8401bd9f1954c36
oai_identifier_str oai:repositorio.unesp.br:11449/173914
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndromeCalcium channelsHeart failureReverse triiodothyronineTherapeutic useTriiodothyronineObjective: The current study was aimed at analyzing sarcoplasmic reticulum Ca2+ ATPase (Serca2) and ryanodine receptor type 2 (Ryr2) gene expression in rats subjected to surgery that induced HF and were subsequently treated with T4 using physiological doses. Materials and methods: HF was induced in 18 male Wistar rats by clipping the ascending thoracic aorta to generate aortic stenosis (HFS group), while the control group (9-sham) underwent thoracotomy. After 21 weeks, the HFS group was subdivided into two subgroups. One group (9 Wistar rats) with HF received 1.0 µg of T4/100 g of body weight for five consecutive days (HFS/T4); the other group (9 Wistar rats) received isotonic saline solution (HFS/S). The animals were sacrificed after this treatment and examined for signs of HF. Samples from the left ventricles of these animals were analyzed by RT-qPCR for the expression of Serca2 and Ryr2 genes. Results: Rats with HF developed euthyroid sick syndrome (ESS) and treatment with T4 restored the T3 values to the Sham level and increased Serca2 and Ryr2 gene expression, thereby demonstrating a possible benefit of T4 treatment for heart function in ESS associated with HF. Conclusion: The T4 treatment can potentially normalize the levels of T3 as well elevated Serca2 and Ryr2 gene expression in the myocardium in heart failure rats with euthyroid sick syndrome.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Departamento de Clínica Médica Unidade de Pesquisa Experimental (Unipex) Faculdade de Medicina de Botucatu Universidade Estadual Paulista (Unesp)Instituto de Ciências da Saúde Universidade Federal de Mato Grosso (UFMT)Departamento de Bioestatística Instituto de Biociências Universidade Estadual Paulista (Unesp)Departamento de Clínica Médica Unidade de Pesquisa Experimental (Unipex) Faculdade de Medicina de Botucatu Universidade Estadual Paulista (Unesp)Departamento de Bioestatística Instituto de Biociências Universidade Estadual Paulista (Unesp)FAPESP: 2007/55902-8Universidade Estadual Paulista (Unesp)Universidade Federal de Mato Grosso (UFMT)Campanha, Fábio V.G. [UNESP]Perone, Denise [UNESP]de Campos, Dijon H.S. [UNESP]de Luvizotto, Renata A. M.de Síbio, Maria T. [UNESP]de Oliveira, Miriane [UNESP]Olimpio, Regiane M. C. [UNESP]Moretto, Fernanda C. F. [UNESP]Padovani, Carlos R. [UNESP]Mazeto, Gláucia M.F.S. [UNESP]Cicogna, Antonio C. [UNESP]Nogueira, Célia R. [UNESP]2018-12-11T17:08:19Z2018-12-11T17:08:19Z2016-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article582-586application/pdfhttp://dx.doi.org/10.1590/2359-3997000000208Archives of Endocrinology and Metabolism, v. 60, n. 6, p. 582-586, 2016.2359-42922359-3997http://hdl.handle.net/11449/17391410.1590/2359-3997000000208S2359-399720160006005822-s2.0-85006051848S2359-39972016000600582.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengArchives of Endocrinology and Metabolism0,5050,505info:eu-repo/semantics/openAccess2024-08-14T17:22:59Zoai:repositorio.unesp.br:11449/173914Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-14T17:22:59Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
title Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
spellingShingle Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
Campanha, Fábio V.G. [UNESP]
Calcium channels
Heart failure
Reverse triiodothyronine
Therapeutic use
Triiodothyronine
title_short Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
title_full Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
title_fullStr Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
title_full_unstemmed Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
title_sort Thyroxine increases Serca2 and Ryr2 gene expression in heart failure rats with euthyroid sick syndrome
author Campanha, Fábio V.G. [UNESP]
author_facet Campanha, Fábio V.G. [UNESP]
Perone, Denise [UNESP]
de Campos, Dijon H.S. [UNESP]
de Luvizotto, Renata A. M.
de Síbio, Maria T. [UNESP]
de Oliveira, Miriane [UNESP]
Olimpio, Regiane M. C. [UNESP]
Moretto, Fernanda C. F. [UNESP]
Padovani, Carlos R. [UNESP]
Mazeto, Gláucia M.F.S. [UNESP]
Cicogna, Antonio C. [UNESP]
Nogueira, Célia R. [UNESP]
author_role author
author2 Perone, Denise [UNESP]
de Campos, Dijon H.S. [UNESP]
de Luvizotto, Renata A. M.
de Síbio, Maria T. [UNESP]
de Oliveira, Miriane [UNESP]
Olimpio, Regiane M. C. [UNESP]
Moretto, Fernanda C. F. [UNESP]
Padovani, Carlos R. [UNESP]
Mazeto, Gláucia M.F.S. [UNESP]
Cicogna, Antonio C. [UNESP]
Nogueira, Célia R. [UNESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade Federal de Mato Grosso (UFMT)
dc.contributor.author.fl_str_mv Campanha, Fábio V.G. [UNESP]
Perone, Denise [UNESP]
de Campos, Dijon H.S. [UNESP]
de Luvizotto, Renata A. M.
de Síbio, Maria T. [UNESP]
de Oliveira, Miriane [UNESP]
Olimpio, Regiane M. C. [UNESP]
Moretto, Fernanda C. F. [UNESP]
Padovani, Carlos R. [UNESP]
Mazeto, Gláucia M.F.S. [UNESP]
Cicogna, Antonio C. [UNESP]
Nogueira, Célia R. [UNESP]
dc.subject.por.fl_str_mv Calcium channels
Heart failure
Reverse triiodothyronine
Therapeutic use
Triiodothyronine
topic Calcium channels
Heart failure
Reverse triiodothyronine
Therapeutic use
Triiodothyronine
description Objective: The current study was aimed at analyzing sarcoplasmic reticulum Ca2+ ATPase (Serca2) and ryanodine receptor type 2 (Ryr2) gene expression in rats subjected to surgery that induced HF and were subsequently treated with T4 using physiological doses. Materials and methods: HF was induced in 18 male Wistar rats by clipping the ascending thoracic aorta to generate aortic stenosis (HFS group), while the control group (9-sham) underwent thoracotomy. After 21 weeks, the HFS group was subdivided into two subgroups. One group (9 Wistar rats) with HF received 1.0 µg of T4/100 g of body weight for five consecutive days (HFS/T4); the other group (9 Wistar rats) received isotonic saline solution (HFS/S). The animals were sacrificed after this treatment and examined for signs of HF. Samples from the left ventricles of these animals were analyzed by RT-qPCR for the expression of Serca2 and Ryr2 genes. Results: Rats with HF developed euthyroid sick syndrome (ESS) and treatment with T4 restored the T3 values to the Sham level and increased Serca2 and Ryr2 gene expression, thereby demonstrating a possible benefit of T4 treatment for heart function in ESS associated with HF. Conclusion: The T4 treatment can potentially normalize the levels of T3 as well elevated Serca2 and Ryr2 gene expression in the myocardium in heart failure rats with euthyroid sick syndrome.
publishDate 2016
dc.date.none.fl_str_mv 2016-01-01
2018-12-11T17:08:19Z
2018-12-11T17:08:19Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/2359-3997000000208
Archives of Endocrinology and Metabolism, v. 60, n. 6, p. 582-586, 2016.
2359-4292
2359-3997
http://hdl.handle.net/11449/173914
10.1590/2359-3997000000208
S2359-39972016000600582
2-s2.0-85006051848
S2359-39972016000600582.pdf
url http://dx.doi.org/10.1590/2359-3997000000208
http://hdl.handle.net/11449/173914
identifier_str_mv Archives of Endocrinology and Metabolism, v. 60, n. 6, p. 582-586, 2016.
2359-4292
2359-3997
10.1590/2359-3997000000208
S2359-39972016000600582
2-s2.0-85006051848
S2359-39972016000600582.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Archives of Endocrinology and Metabolism
0,505
0,505
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 582-586
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128142271840256